The clinical and immunologic features of pulmonary fibrosis in sarcoidosis.

The clinical and immunologic features of pulmonary fibrosis in sarcoidosis.
复制标题

DOI:
10.1016/j.trsl.2012.03.005
复制
发表时间:
2012-11
期刊:
Translational research : the journal of laboratory and clinical medicine
影响因子:
--
通讯作者:
Niewold TB
Niewold TB
中科院分区:
其他
文献类型:
--
作者:
Patterson KC;Hogarth K;Husain AN;Sperling AI;Niewold TB

文献摘要

参考文献

被引文献

相似文献

Sarcoidosis is a multisystem, granulomatous disease that most often affects the lungs. The clinical course is highly variable; many patients undergo spontaneous remission, but up to a third of patients progresses to a chronic disease course. The development of pulmonary fibrosis (PF) in a subset of patients with chronic disease has a negative impact on morbidity and mortality. While sarcoidosis-associated PF can be progressive, it is often referred to as “burnt out” disease, a designation reflecting inactive granulomatous inflammation. The immune mechanisms of sarcoidosis-associated PF are not well understood. It is not clear if fibrotic processes are active from the onset of sarcoidosis in predisposed individuals, or whether a profibrotic state develops as a response to ongoing inflammation. Transforming growth factor β (TGF-β) is an important profibrotic cytokine, and in sarcoidosis, distinct genotypes of TGF-β have been identified in those with PF. The overall cytokine profile in sarcoidosis-associated PF has not been well characterized, although a transition from a T helper 1 to a T helper 2 signature has been proposed. Macrophages have important regulatory interactions with fibroblasts, and the role of alveolar macrophages in sarcoidosis-associated PF is a compelling target for further study. Elucidating the natural history of sarcoidosis-associated PF will inform our understanding of the fundamental derangements, and will enhance prognostication and the development of therapeutic strategies.
DOI: 10.1001/jama.2011.10
发表时间: 2011-01-26
影响因子: 120.7
作者:
Iannuzzi, Michael C.;Fontana, Joseph R.
通讯作者: Fontana, Joseph R.
DOI: 10.1164/ajrccm/144.5.1080
发表时间: 1991-11-01
期刊: AMERICAN REVIEW OF RESPIRATORY DISEASE
影响因子: --
作者:
BOROK, Z;GILLISSEN, A;CRYSTAL, RG
通讯作者: CRYSTAL, RG
DOI: 10.1034/j.1399-3003.1999.13f18.x
发表时间: 1999-06-01
影响因子: 24.3
作者:
Drent, M;Jacobs, JA;Wouters, EFM
通讯作者: Wouters, EFM
DOI: 10.2214/ajr.174.6.1741751
发表时间: 2000-06-01
影响因子: 5
作者:
Abehsera, M;Valeyre, D;Brauner, MW
通讯作者: Brauner, MW
DOI: 10.1165/rcmb.2011-0025rt
发表时间: 2011-09-01
影响因子: 6.4
作者:
Bozyk, Paul D.;Moore, Bethany B.
通讯作者: Moore, Bethany B.